Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Am J Drug Alcohol Abuse ; 38(1): 101-7, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21851195

RESUMEN

BACKGROUND: It has been shown that the partial N-methyl-d-aspartate (NMDA) agonist d-cycloserine (DCS) facilitates exposure-based learning in humans with anxiety disorders. However, the effects of DCS on exposure to substance cues are still uncertain. OBJECTIVE: The primary aim of the study was to examine the effects of DCS on exposure sessions to alcohol cues. METHODS: Twenty non-treatment-seeking problem drinkers were randomly assigned to receive 50 mg of DCS or placebo 50 minutes prior to each of 3 alcohol cue exposure sessions consisting of 5 exposure trials within an 8-day period. Following this, participants underwent two test sessions without the administration of any medication. The test sessions occurred 3 and 7 days after the last cue exposure session, respectively. Dependent measures included drinking urge and heart rate and drinking urge during the test sessions. RESULTS: Individuals who received DCS showed increased craving to alcohol cues as compared with individuals who received placebo during the first test session. No group difference in drinking urge was found during the second test session. Furthermore, the groups did not differ in heart rate at any of the assessment points. CONCLUSIONS: The results suggest that DCS may temporarily augment cue-elicited craving for alcohol. SCIENTIFIC SIGNIFICANCE: As in an earlier study with cocaine-dependent individuals, DCS appears to exhibit a different profile in problem drinkers to those with anxiety disorders. Dose, timing, arousal, and treatment motivation as considerations are discussed, as are methodological considerations and the need for additional studies in this area.


Asunto(s)
Consumo de Bebidas Alcohólicas/tratamiento farmacológico , Alcoholismo/tratamiento farmacológico , Señales (Psicología) , Cicloserina/uso terapéutico , Adulto , Nivel de Alerta/efectos de los fármacos , Conducta/efectos de los fármacos , Cicloserina/farmacología , Humanos , Masculino , Persona de Mediana Edad , Motivación , Resultado del Tratamiento
2.
Behav Res Ther ; 47(4): 345-52, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19223029

RESUMEN

Individuals with acrophobia experience anxiety and dizziness when exposed to heights. It may be that their balance system is disturbed and that they therefore have to rely more strongly on visual information. We tested this hypothesis by exposing 20 individuals with high fear of heights and 20 healthy control participants to nine different visual flow stimuli through a head mounted display, thereby inducing a conflict between visual input and somatosensory information. Anxiety and dizziness were assessed repeatedly by means of self-reports, while resultant body sway was measured continuously with a force plate individuals stood on. Individuals with fear of heights felt more anxious and dizzier, and also showed stronger body sway than healthy control participants. Merely receiving visual balance information contradictory to somatosensory balance information is sufficient to induce anxiety, dizziness, and body sway in individuals with fear of heights. An underlying balance dysfunction may contribute to the development of height phobia.


Asunto(s)
Ansiedad , Mareo/psicología , Trastornos Fóbicos/psicología , Equilibrio Postural/fisiología , Altitud , Femenino , Humanos , Trastornos Fóbicos/fisiopatología , Estimulación Luminosa/métodos , Escalas de Valoración Psiquiátrica , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA